Cayman Islands-based Bullish targets US public offering following earlier SPAC failure, operating through subsidiaries in six ...

Shares of Alphabet Inc. were gaining on Friday, putting the company on pace for an eight-day winning streak - its longest in about 10 months. Will the positive momentum carry forward into next week, ...

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on Merck & Co.

Oasis continue to play to sell out crowds on their tour but if they want to release new music there are some interesting options from the past ...

Chevron prevails over Exxon in Hess megamerger, and it matters for Chevron's stock. Chevron Corp. investors breathed a little ...

The firm said that while Clarivate’s valuation remains attractive, it now expects revenue in 2026 to be roughly flat compared to 2025, with risks building from potential U.S. government funding cuts ...

Abbott Laboratories ( NYSE: ABT) was upgraded to Buy from Hold at Jefferies following its Q2 results and revised guidance, as ...

Jefferies has added five new stocks to its EMEA Franchise Picks list, selecting Assa Abloy (ST: ASSAb), British American ...

Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...

Fintel reports that on July 18, 2025, Jefferies downgraded their outlook for Mesoblast Limited - Depositary Receipt () (NasdaqGS:MESO) from Buy to Hold. Analyst Price Forecast Suggests 3.07% Downside ...